Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digital Pills for PrEP Adherence in MSM with Substance Use
NCT03842436Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Oct 2018
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Brigham and Women's Hospital. Started Oct 2018; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03842436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03842436.